{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Hu WZ"],"pubmed_abstract":["Background
Non-motor symptoms (NMS) are compulsory clinical features for the clinical diagnosis of multiple system atrophy (MSA), some of which precede motor symptoms onset. To date, few studies have systematically investigated NMS in MSA and the timing of presenting NMS as the disease progresses. Clinically, MSA is difficult to be differentiated from Parkinson's disease (PD) and progressive supranuclear palsy (PSP), and the differences in NMS between MSA and PD/PSP remain unclear. The aim of this study was to compare the burden of NMS between MSA and PD/PSP and to delineate the timing of NMS presentation relative to the onset of motor symptoms in MSA.Methods
A total of 61, 87, and 30 patients with MSA, PD, and PSP, respectively, were enrolled in this study. NMS was systema"],"journal":["Frontiers in neurology"],"pagination":["1081219"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9901543"],"repository":["biostudies-literature"],"pubmed_title":["Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy."],"pmcid":["PMC9901543"],"pubmed_authors":["Ma JH","Huang Y","Cao LX","Yin JH","Hu WZ","Piao YS","Wan ZR","Zhao XS","Gu WH"],"additional_accession":[]},"is_claimable":false,"name":"Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy.","description":"Background
Non-motor symptoms (NMS) are compulsory clinical features for the clinical diagnosis of multiple system atrophy (MSA), some of which precede motor symptoms onset. To date, few studies have systematically investigated NMS in MSA and the timing of presenting NMS as the disease progresses. Clinically, MSA is difficult to be differentiated from Parkinson's disease (PD) and progressive supranuclear palsy (PSP), and the differences in NMS between MSA and PD/PSP remain unclear. The aim of this study was to compare the burden of NMS between MSA and PD/PSP and to delineate the timing of NMS presentation relative to the onset of motor symptoms in MSA.Methods
A total of 61, 87, and 30 patients with MSA, PD, and PSP, respectively, were enrolled in this study. NMS was systema","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T12:56:03.255Z","creation":"2025-04-04T12:56:03.255Z"},"accession":"S-EPMC9901543","cross_references":{"pubmed":["36756345"],"doi":["10.3389/fneur.2022.1081219"]}}